[1] COLLINS F S, GREEN E S, GUTTMACHER A E, et al. A vision for the future of genomics research[J] . Nature, 2003, 422: 835-847. [2] JOHN R. Metabolomics——an important emerging science.Business briefing：pharmatech[J] . Drug Discov Today, 2004, 1:51-54. [3] OLIVER S G, WINSON M K, KELL D B, et al. Systermatic functional analysis of the yeast genome[J] . Trends Biotechnol, 1998, 16:373-379. [4] NICHOLSON J K, CONNELLY J, LINDON J C, et al. Metabonomics: A platform for studying drug toxicity and gene function[J] . Nat Rev Drug Discov, 2002, 1:153-159. [5] THOMAS G H. Metabolomics breaks the silence[J] . Trends Microbiol, 2001, 9（4）:158-159. [6] WAGNER P. Analytical techniques Innovation, integration, information[J] . Curr Opin Biotechnol, 2003, 7:592-597. [7] SCHMIDT C. Metabolomics takes its place as latest Up-and-coming “Omic” science[J] . J Natl Cancer Inst, 2004, 96：732-734. [8] NICHOLSON J K, WILSON I D. Understanding `global' systems biology: metabonomics and the continuum of metabolism[J] . Nat Rev Drug Discov, 2003, 2:668-676. [9] WECKWERTH W, FIEHN O. Can we discover novel pathways using metabolomic analysis?[J] .Curr Opin Biotechnol, 2002, 13:156-161. [10] HOLMES E, ANTTI H. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterizing and interpreting complex biological NMR spectra[J] . Analyst, 2002, 127:1549-1557. [11] LI J, WU X J, LIU C X, et al. Research and application of new method for data processing in metabonomics studies[J] . Acta Pharm Sin(药学学报)，2006，41(1)：47-53. [12] HUBERT M, ENGELEN S. Robust PCA and classification in biosciences[J] . Bioinformatics, 2004, 20 (11)：1728-1736. [13] SCHOLZ M, GATZEK S, STERLING A, et al. Metabolite fingerprinting: detecting biological features by independent component analysis[J] . Bioinformatics, 2004, 20 (15)：2447-2455. [14] JANSEN J J, HOEFSLOOT H, BOELENS H, et al. Analysis of longitudinal metabolomics data[J] . Bioinformatics, 2004, 20 (15)：2438-2461. [15] ERIKSSON L, ANTTI H, GOTTFRIES J. Using chemometrics for navigating in the large data sets of genomics, proteomics and metabonomics (gpm)[J] . Anal Bioanal Chem, 2004, 380：419-429. [16] WU X J, LI J, YUAN Y J. Progress and perspective in application of bioinformatics to metabonomics and metabolomics[J] . J Chem Ind Eng(化工学报), 2005，56：1819-1825. [17] ANETOR J I, ADENIYI A A, OLALEYE S B. Molecular epidemiology: A better approach for the early detection of pathophysiologic response to environmental toxicants and disease[J] .African J Biomedical Res, 2003, 6：146-147. [18] NOONAN C W，SARASUA S M，CAMPAGNA D，Effect of exposure to low levels of environmental cadmium on renal biomarkers[J] . Environ Health Perspect, 2002, 110：151-155. [19] MUELLER M, KERSTEN S. Nutrigenomics: goals and strategies[J] . Nat Rev Genet, 2003，4：315-323. [20] MATHERS J C. What can we expect to learn from genomics?[J] . Proc Nutr Soc, 2004，63：1-4. [21] GERMAN J B, ROBERTS M A, WATKINSZ S M. Genomics and metabolomics as markers for the interaction of diet and health：lessons from lipids[J] . J Nutr, 2003, 133：2078-2083. [22] AARDEMA M J, MACGREGOR J T. Toxicology and genetic toxicology in the new era of “toxicogenomics”: impact of “-omics” technologies[J] . Mutat Res Fund Mol Mech Mutagen, 2002, 499：13-25. [23] NICHOLSON J K, WILSON I D. High resolution proton magnetic resonance spectroscopy of biological fluids[J] . Prog NMR Spectrosc, 1989, 21:444-501. [24] GRIFFIN J L, WALKER L A, SHORE R F, et al. Metabolic profiling of chronic cadmium exposure in the rat[J] . Chem Res Toxicol, 2001,14：1428-1434. [25] GRIFFIN J L, WALKER L, SHORE R F，et al. High-resolution magic angle spinning 1H-NMR spectroscopy studies on the renal biochemistry in the bank vole (Clethrionomys glareolus) and the effects of arsenic (As3+) toxicity[J] . Xenobiotica, 2001, 31(6):377-385. [26] BUNDY J G, LENZ E M, BAILEY N J. Metabonomic investigation into the toxicity of 4-fluoroaniline, 3,5-difluoroaniline and 2-fluoro-4-methylaniline to the earthworm Eisenia veneta(Rosa): identification of novel endogenous biomarkers[J] . Environ Toxicol Chem, 2002, 21:1966-1972. [27] LAFAYE A, JUNOT C, GALL B R, et al. Metabolite profiling in rat urine by liquid chromatography/ electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicity Rapid Commun[J] . Mass Spectrom, 2003, 17:2541-2549. [28] WATKINS S M, REIFSNYDER P R, PAN H J, et al. Lipid metabolome-wide effects of the peroxisome proliferator-activated receptor gamma agonist rosiglitazone[J] . J Lipid Res, 2002，43(11)：1809-1817. [29] HAN X, GROSS R W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics[J] . J Lipid Res, 2003, 44: 1071-1079. [30] SU X, HAN X, YANG J, et al. Sequential ordered fatty acid a oxidation and D9 desaturation are major determinants of lipid storage and utilization in differentiating adipocytes[J] . Biochem, 2004, 43:5033-5044. [31] LAMERS R J, GROOT J D, FABER F G. Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic guinea pigs[J] .J Nutr，2003，133：1776-1780. [32] CATCHPOLE G S, BECKMANN M, ENOT D P, et al. Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops[J] .Proc Natl Acad Sci USA, 2005, 102：14458-14462. [33] TEAGUE C, HOLMES E, MAIBAUM E, et al. Ethyl glucoside in human urine following dietary exposure: detection by 1H-NMR spectroscopy as a result of metabonomic screening in humans[J] . Analyst，2004, 129：259-265. [34] SOLANKY K S, BAILEY N J, BECKWITH-HALL B M, et al. Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile[J] . Anal Biochem, 2003, 323:197-204. [35] HOLMES E, NICHOLSON J K, NICHOLLS A W, et al. The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine[J] . Chemom Intell Lab Syst, 1998, 44:245-255. [36] HOLMES E, NICHOLSON J K, TRANTER G. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks[J] . Chem Res Toxicol, 2001,14:182-192. [37] COEN M, LENZ E M, NICHOLSON J K, et al. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy[J] . Chem Res Toxicol, 2003, 16:295-303. [38] COEN M, RUEPP S U, LINDON J C, et al. Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse[J] . J Pharm Biomed Anal, 2004, 35(1):93-105. [39] LINDON J C, NICHOLSON J K, HOLMES E, et al. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project[J] . Toxicol Appl Pharmacol, 2003, 187:137-146. [40] KEUN H C, EBBELS T M D, ANTTI H, et al. Analytical reproducibility in 1H-NMR-based metabonomic urinalysis[J] . Chem Res Toxicol, 2002，15：1380-1386. [41] PLUMB R, GRANGER J, STUMPF C, et al. Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LCTOFMS)：detection of strain, diurnal and gender differences[J] . Analyst，2003，128：819-826. [42] BJORKMAN H I, EDLUND P O, KVALHEIM O M, et al. Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two way data analysis[J] .Anal Chem, 2003, 75:4784-4792. [43] LIU C X, LI C, LIN D H, et al. Significance of metabonomics in drug discovery and development[J] .Asian J Drug Metab Pharmacokinet, 2004, 4(2):87-96.